Article
Loss of Spindly sensitizes EML4-ALK v3 lung cancer cells to HSP90 inhibitors
bioRxiv · 2022 · Marco P. Licciardello
Key facts
| Title | Loss of Spindly sensitizes EML4-ALK v3 lung cancer cells to HSP90 inhibitors |
|---|---|
| First author | Marco P. Licciardello |
| Journal | bioRxiv |
| Published | Jun 8, 2022 |
| DOI | 10.1101/2022.06.08.495301 |
| Devices mentioned | 212969 |
| Product codes mentioned | JJH, JJQ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1